[Form 4] Natera, Inc. Insider Trading Activity
Moshkevich Solomon, President, Clinical Diagnostics at Natera, Inc. (NTRA), reported equity transactions relating to previously granted restricted stock units. On 08/12/2025, 1,675 RSUs vested after certification of milestone achievement; each RSU converts into one share. Following vesting the reporting person beneficially owned 124,734 shares. On 08/14/2025 the reporting person sold 867 shares at $155.46 and 8 shares at $155.4248 to satisfy tax withholding obligations under a written instruction intended to meet Rule 10b5-1 affirmative defense, leaving 123,859 shares beneficially owned. The Form 4 is signed by an attorney-in-fact on 08/15/2025.
Moshkevich Solomon, Presidente, Clinical Diagnostics presso Natera, Inc. (NTRA), ha comunicato operazioni su azioni relative a restricted stock units precedentemente assegnate. In data 12/08/2025 si sono vestite 1.675 RSU dopo la certificazione del raggiungimento di un traguardo; ogni RSU si converte in una azione. Dopo il vesting la persona segnalante risultava titolare beneficiaria di 124.734 azioni. Il 14/08/2025 la persona segnalante ha venduto 867 azioni a $155,46 e 8 azioni a $155,4248 per soddisfare obblighi di ritenuta fiscale ai sensi di una istruzione scritta finalizzata a ottenere la difesa affermativa prevista dalla Rule 10b5-1, rimanendo con 123.859 azioni beneficiarie. Il Modulo Form 4 猫 firmato da un procuratore il 15/08/2025.
Moshkevich Solomon, Presidente de Clinical Diagnostics en Natera, Inc. (NTRA), inform贸 transacciones de valores relacionadas con unidades de acciones restringidas previamente otorgadas. El 12/08/2025 se consolidaron 1.675 RSU tras la certificaci贸n del logro de un hito; cada RSU se convierte en una acci贸n. Tras el consolidamiento, la persona informante pose铆a 124.734 acciones en beneficio propio. El 14/08/2025 la persona informante vendi贸 867 acciones a $155,46 y 8 acciones a $155,4248 para cubrir obligaciones fiscales bajo una instrucci贸n escrita destinada a amparar la defensa afirmativa de la Rule 10b5-1, quedando con 123.859 acciones en propiedad beneficiaria. El Formulario 4 fue firmado por un apoderado el 15/08/2025.
Moshkevich Solomon, Natera, Inc. (NTRA) 鞛勳儊歆勲嫧 攵�氍� 雽�響滊姅 鞚挫爠鞐� 攵�鞐悳 鞝滍暅攵� 欤检嫕雼渼(RSU)鞕� 甏�霠暅 歆�攵� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 2025-08-12鞐� 靹标臣 雼劚 鞚胳 頉� 1,675 RSU臧� 頇曥爼(vest)霅橃棃鞙茧┌, 臧� RSU電� 1欤茧 鞝勴櫂霅╇媹雼�. 頇曥爼 頉� 氤搓碃鞛愲姅 124,734欤茧ゼ 鞁れ唽鞙�(beneficially owned)頃橁碃 鞛堨棃鞀惦媹雼�. 2025-08-14鞐� 氤搓碃鞛愲姅 靹戈笀 鞗愳矞歆曥垬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 攴滌爼 10b5-1鞚� 鞝侁饭鞝� 氚╈柎(affirmative defense)毳� 頇曤炒頃橁赴 鞙勴暅 靹滊┐ 歆�旃棎 霐半澕 867欤茧ゼ 欤茧嫻 $155.46鞐�, 8欤茧ゼ 欤茧嫻 $155.4248鞐� 毵る弰頃橃棳 123,859欤茧ゼ 鞁れ唽鞙犿晿瓴� 霅橃棃鞀惦媹雼�. Form 4電� 2025-08-15鞐� 雽�毽澑(氩曥爼雽�毽澑)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.
Moshkevich Solomon, Pr茅sident de Clinical Diagnostics chez Natera, Inc. (NTRA), a d茅clar茅 des op茅rations sur titres relatives 脿 des unit茅s d'actions restreintes (RSU) pr茅c茅demment attribu茅es. Le 12/08/2025, 1 675 RSU ont acquis le droit de conversion apr猫s la certification de l'atteinte d'un jalon ; chaque RSU se convertit en une action. Apr猫s ce vesting, la personne d茅clarant d茅tenait b茅n茅ficiairement 124 734 actions. Le 14/08/2025, la personne d茅clarant a vendu 867 actions 脿 155,46 $ et 8 actions 脿 155,4248 $ pour satisfaire des obligations de retenue fiscale conform茅ment 脿 une instruction 茅crite visant 脿 soutenir la d茅fense affirmative de la Rule 10b5-1, restant ainsi propri茅taire b茅n茅ficiaire de 123 859 actions. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 15/08/2025.
Moshkevich Solomon, Pr盲sident von Clinical Diagnostics bei Natera, Inc. (NTRA), meldete Wertpapiertransaktionen im Zusammenhang mit zuvor gew盲hrten Restricted Stock Units. Am 12.08.2025 sind 1.675 RSUs nach der Zertifizierung der Erreichung eines Meilensteins vestet; jede RSU wandelt sich in eine Aktie um. Nach dem Vesting hielt die meldende Person wirtschaftlich 124.734 Aktien. Am 14.08.2025 verkaufte die meldende Person 867 Aktien zu $155,46 und 8 Aktien zu $155,4248, um Steuerabzugsverpflichtungen gem盲脽 einer schriftlichen Anweisung zur Absicherung der Rule-10b5-1-Affirmativverteidigung zu erf眉llen, und verblieb mit 123.859 wirtschaftlich gehaltenen Aktien. Das Formular 4 wurde am 15.08.2025 von einem Bevollm盲chtigten unterzeichnet.
- Transactions executed under a 10b5-1 instruction, indicating pre-arranged compliance with insider trading rules
- RSU vesting confirmed by certification, showing achievement of the specified milestone conditions
- None.
Insights
TL;DR: Routine executive vesting and tax-sale transactions consistent with pre-established equity plan and 10b5-1 procedures.
The filing documents the vesting of performance/time-based RSUs granted in 2021 and immediate disposition of a portion of shares to satisfy tax withholding. Use of a written instruction intended to satisfy Rule 10b5-1 suggests the transactions were pre-arranged to avoid trading-window issues. Beneficial ownership moved from 124,734 to 123,859 shares after the sales, indicating a modest change in holdings without additional purchases or exercises reported.
TL;DR: The report shows expected vesting mechanics and customary sell-to-cover for tax obligations on RSU settlement.
The RSUs were originally granted on October 22, 2021 for 10,000 shares and vested in tranches upon milestone certification; 1,675 shares vested on 08/12/2025. The subsequent sales of 875 shares in total were executed at roughly $155.43 per share to satisfy withholding obligations as described in the RSU agreement. No derivative transactions or additional awards are disclosed in this Form 4.
Moshkevich Solomon, Presidente, Clinical Diagnostics presso Natera, Inc. (NTRA), ha comunicato operazioni su azioni relative a restricted stock units precedentemente assegnate. In data 12/08/2025 si sono vestite 1.675 RSU dopo la certificazione del raggiungimento di un traguardo; ogni RSU si converte in una azione. Dopo il vesting la persona segnalante risultava titolare beneficiaria di 124.734 azioni. Il 14/08/2025 la persona segnalante ha venduto 867 azioni a $155,46 e 8 azioni a $155,4248 per soddisfare obblighi di ritenuta fiscale ai sensi di una istruzione scritta finalizzata a ottenere la difesa affermativa prevista dalla Rule 10b5-1, rimanendo con 123.859 azioni beneficiarie. Il Modulo Form 4 猫 firmato da un procuratore il 15/08/2025.
Moshkevich Solomon, Presidente de Clinical Diagnostics en Natera, Inc. (NTRA), inform贸 transacciones de valores relacionadas con unidades de acciones restringidas previamente otorgadas. El 12/08/2025 se consolidaron 1.675 RSU tras la certificaci贸n del logro de un hito; cada RSU se convierte en una acci贸n. Tras el consolidamiento, la persona informante pose铆a 124.734 acciones en beneficio propio. El 14/08/2025 la persona informante vendi贸 867 acciones a $155,46 y 8 acciones a $155,4248 para cubrir obligaciones fiscales bajo una instrucci贸n escrita destinada a amparar la defensa afirmativa de la Rule 10b5-1, quedando con 123.859 acciones en propiedad beneficiaria. El Formulario 4 fue firmado por un apoderado el 15/08/2025.
Moshkevich Solomon, Natera, Inc. (NTRA) 鞛勳儊歆勲嫧 攵�氍� 雽�響滊姅 鞚挫爠鞐� 攵�鞐悳 鞝滍暅攵� 欤检嫕雼渼(RSU)鞕� 甏�霠暅 歆�攵� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 2025-08-12鞐� 靹标臣 雼劚 鞚胳 頉� 1,675 RSU臧� 頇曥爼(vest)霅橃棃鞙茧┌, 臧� RSU電� 1欤茧 鞝勴櫂霅╇媹雼�. 頇曥爼 頉� 氤搓碃鞛愲姅 124,734欤茧ゼ 鞁れ唽鞙�(beneficially owned)頃橁碃 鞛堨棃鞀惦媹雼�. 2025-08-14鞐� 氤搓碃鞛愲姅 靹戈笀 鞗愳矞歆曥垬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 攴滌爼 10b5-1鞚� 鞝侁饭鞝� 氚╈柎(affirmative defense)毳� 頇曤炒頃橁赴 鞙勴暅 靹滊┐ 歆�旃棎 霐半澕 867欤茧ゼ 欤茧嫻 $155.46鞐�, 8欤茧ゼ 欤茧嫻 $155.4248鞐� 毵る弰頃橃棳 123,859欤茧ゼ 鞁れ唽鞙犿晿瓴� 霅橃棃鞀惦媹雼�. Form 4電� 2025-08-15鞐� 雽�毽澑(氩曥爼雽�毽澑)鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.
Moshkevich Solomon, Pr茅sident de Clinical Diagnostics chez Natera, Inc. (NTRA), a d茅clar茅 des op茅rations sur titres relatives 脿 des unit茅s d'actions restreintes (RSU) pr茅c茅demment attribu茅es. Le 12/08/2025, 1 675 RSU ont acquis le droit de conversion apr猫s la certification de l'atteinte d'un jalon ; chaque RSU se convertit en une action. Apr猫s ce vesting, la personne d茅clarant d茅tenait b茅n茅ficiairement 124 734 actions. Le 14/08/2025, la personne d茅clarant a vendu 867 actions 脿 155,46 $ et 8 actions 脿 155,4248 $ pour satisfaire des obligations de retenue fiscale conform茅ment 脿 une instruction 茅crite visant 脿 soutenir la d茅fense affirmative de la Rule 10b5-1, restant ainsi propri茅taire b茅n茅ficiaire de 123 859 actions. Le formulaire 4 a 茅t茅 sign茅 par un mandataire le 15/08/2025.
Moshkevich Solomon, Pr盲sident von Clinical Diagnostics bei Natera, Inc. (NTRA), meldete Wertpapiertransaktionen im Zusammenhang mit zuvor gew盲hrten Restricted Stock Units. Am 12.08.2025 sind 1.675 RSUs nach der Zertifizierung der Erreichung eines Meilensteins vestet; jede RSU wandelt sich in eine Aktie um. Nach dem Vesting hielt die meldende Person wirtschaftlich 124.734 Aktien. Am 14.08.2025 verkaufte die meldende Person 867 Aktien zu $155,46 und 8 Aktien zu $155,4248, um Steuerabzugsverpflichtungen gem盲脽 einer schriftlichen Anweisung zur Absicherung der Rule-10b5-1-Affirmativverteidigung zu erf眉llen, und verblieb mit 123.859 wirtschaftlich gehaltenen Aktien. Das Formular 4 wurde am 15.08.2025 von einem Bevollm盲chtigten unterzeichnet.
FAQ
What did NTRA insider Moshkevich Solomon report on Form 4?
Why were shares sold after the RSU vesting?
Were the sales part of a pre-arranged trading plan?
How many shares does the reporting person beneficially own after these transactions?
When were the RSUs originally granted?
